Some Biochemical Markers in Patients with Alzheimer's Disease.

Mohammad Khanahmadi, Dariush D Farhud, Maryam Malmir, Soheila Orang

Open access · greenAbstract read

In one paragraph

Article in Iranian journal of public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 87% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mohammad KhanahmadiAging Research Center, Farhud Scientific-Cultural Foundation, Tehran, Iran.

Dariush D FarhudSchool of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Dept. of Basic Sciences/Ethics, Iranian Academy of Medical Sciences, Tehran, Iran.

Maryam MalmirResearch Center of Life Style, Medical Sciences Branch, Islamic Azad University, Tehran, Iran.

Soheila OrangDept. of Psychology, Kharazmi University, Tehran, Iran.

Kharazmi University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetal ions effect on homeostasis of Alzheimer's disease (AD) patients. The aim of this study was to assess the metal ions (Iron, Zinc and Copper) and CBC in patients with AD in comparison with normal range.

methodsThe samples of study were 17 patients with AD in Tehran's aging centers in 2015, selected as an access sample. Blood samples were analyzed in a pathobiology laboratory. Data were analyzed by one sample

resultsAccording to the normal range, provided by laboratory, there is a significant difference between zinc in patients with AD and normal reference interval (α=0.01). The comparison of CBC of the AD patients with normal group showed also some decreases.

conclusionZinc value in AD patients is significantly lower than normal range. It should be repeated by a larger sample size.

Indexed as

Alzheimer’s diseaseCopperIronZinc

Identifiers

PMID27957443

PMCPMC5149500

OpenAlexW2544654208

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.